Insights into the Interaction between Influenza Virus and Pneumococcus
暂无分享,去创建一个
[1] J. Rehg,et al. Induction of pro- and anti-inflammatory molecules in a mouse model of pneumococcal pneumonia after influenza. , 2007, Comparative medicine.
[2] Vincent A. Fischetti,et al. Gram-positive pathogens , 2006 .
[3] J. McCullers. Influenza mutations: trying to hit a moving target , 2006 .
[4] J. Rehg,et al. Bacterial Sinusitis and Otitis Media following Influenza Virus Infection in Ferrets , 2006, Infection and Immunity.
[5] E. Tuomanen,et al. Multifunctional Role of Choline Binding Protein G in Pneumococcal Pathogenesis , 2006, Infection and Immunity.
[6] T. Hovi,et al. Is there any specific association between respiratory viruses and bacteria in acute otitis media of young children? , 2005, Journal of Infection.
[7] David E. Swayne,et al. Pathogenicity of Influenza Viruses with Genes from the 1918 Pandemic Virus: Functional Roles of Alveolar Macrophages and Neutrophils in Limiting Virus Replication and Mortality in Mice , 2005, Journal of Virology.
[8] R. Dales,et al. In a retrospective study of chronic obstructive pulmonary disease inpatients, respiratory comorbidities were significantly associated with prognosis. , 2005, Journal of clinical epidemiology.
[9] Tamara Pilishvili,et al. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. , 2005, JAMA.
[10] David E. Swayne,et al. Characterization of the Reconstructed 1918 Spanish Influenza Pandemic Virus , 2005, Science.
[11] Jeffery K. Taubenberger,et al. Characterization of the 1918 influenza virus polymerase genes , 2005, Nature.
[12] Angus Nicoll,et al. Avian influenza A (H5N1) infection in humans. , 2005, The New England journal of medicine.
[13] D. Isaacman,et al. Streptococcus pneumoniae: Description of the Pathogen, Disease Epidemiology, Treatment, and Prevention , 2005, Pharmacotherapy.
[14] Stephen S Morse,et al. Epidemiological evidence of an early wave of the 1918 influenza pandemic in New York City. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[15] J. McCullers,et al. Influenza virus neuraminidase contributes to secondary bacterial pneumonia. , 2005, The Journal of infectious diseases.
[16] A. Melegaro,et al. A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting , 2005, Epidemiology and Infection.
[17] S. Obaro,et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial , 2005, The Lancet.
[18] J. Weiser,et al. Synergistic proinflammatory responses induced by polymicrobial colonization of epithelial surfaces. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[19] Albert D. M. E. Osterhaus,et al. Characterization of a Novel Influenza A Virus Hemagglutinin Subtype (H16) Obtained from Black-Headed Gulls , 2005, Journal of Virology.
[20] S. Akira,et al. Involvement of Toll-like Receptor 3 in the Immune Response of Lung Epithelial Cells to Double-stranded RNA and Influenza A Virus* , 2005, Journal of Biological Chemistry.
[21] Cecile Viboud,et al. Impact of influenza vaccination on seasonal mortality in the US elderly population. , 2005, Archives of internal medicine.
[22] K. Maitland,et al. Bacteremia among children admitted to a rural hospital in Kenya. , 2005, The New England journal of medicine.
[23] J. McCullers,et al. The Novel Parainfluenza Virus Hemagglutinin-Neuraminidase Inhibitor BCX 2798 Prevents Lethal Synergism between a Paramyxovirus and Streptococcus pneumoniae , 2005, Antimicrobial Agents and Chemotherapy.
[24] Jonathan A. McCullers,et al. Multiple Genotypes of Influenza B Virus Circulated between 1979 and 2003 , 2004, Journal of Virology.
[25] E. Tuomanen,et al. Tissue-specific contributions of pneumococcal virulence factors to pathogenesis. , 2004, The Journal of infectious diseases.
[26] Mark A. Miller,et al. Influenza and the winter increase in mortality in the United States, 1959-1999. , 2004, American journal of epidemiology.
[27] J. McCullers. Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza. , 2004, The Journal of infectious diseases.
[28] B. Beutler,et al. Inferences, questions and possibilities in Toll-like receptor signalling , 2004, Nature.
[29] Y. Guan,et al. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia , 2004, Nature.
[30] M. Levine,et al. Invasive Pneumococcal Infections Among Hospitalized Children in Bamako, Mali , 2004, The Pediatric infectious disease journal.
[31] L. Bakaletz. Developing animal models for polymicrobial diseases , 2004, Nature Reviews Microbiology.
[32] T. van der Poll,et al. IL-10 Is an Important Mediator of the Enhanced Susceptibility to Pneumococcal Pneumonia after Influenza Infection , 2004, The Journal of Immunology.
[33] J. Rehg,et al. A ferret model of synergism between influenza virus and Streptococcus pneumoniae , 2004 .
[34] H. Wagner,et al. MyD88 is required for mounting a robust host immune response to Streptococcus pneumoniae in the CNS. , 2004, Brain : a journal of neurology.
[35] Akiko Iwasaki,et al. Recognition of single-stranded RNA viruses by Toll-like receptor 7. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[36] Kurt Olsen,et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. , 2004, Pediatrics.
[37] A. Sandgren,et al. Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae. , 2004, The Journal of infectious diseases.
[38] P. Andrew,et al. The innate immune response to pneumococcal lung infection: the untold story. , 2004, Trends in immunology.
[39] Colin Mathers,et al. The Global epidemiology of infectious diseases , 2004 .
[40] R. Webster,et al. Are We Ready for Pandemic Influenza? , 2003, Science.
[41] A. Ortqvist,et al. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in elderly people: a 1-year follow-up. , 2003, Vaccine.
[42] P. Ward,et al. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. , 2003, Archives of internal medicine.
[43] Jonathan W. Yewdell,et al. The Influenza A Virus PB1-F2 Protein Targets the Inner Mitochondrial Membrane via a Predicted Basic Amphipathic Helix That Disrupts Mitochondrial Function , 2003, Journal of Virology.
[44] K. Stöhr. Preventing and treating influenza , 2003, BMJ : British Medical Journal.
[45] A. Sutton,et al. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials , 2003, BMJ : British Medical Journal.
[46] A. Monto,et al. The role of antivirals in the control of influenza. , 2003, Vaccine.
[47] T. Heikkinen,et al. Importance of Respiratory Viruses in Acute Otitis Media , 2003, Clinical Microbiology Reviews.
[48] J. McCullers,et al. Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. , 2003, The Journal of infectious diseases.
[49] M. Lipsitch,et al. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[50] Keiji Fukuda,et al. Mortality associated with influenza and respiratory syncytial virus in the United States. , 2003, JAMA.
[51] Y. Guan,et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? , 2002, The Lancet.
[52] K. Frei,et al. Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. , 2002, The Journal of infectious diseases.
[53] J. Rehg,et al. Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. , 2002, The Journal of infectious diseases.
[54] T. Demaria,et al. Comparison of structural changes of cell surface carbohydrates in the eustachian tube epithelium of chinchillas infected with a Streptococcus pneumoniae neuraminidase-deficient mutant or its isogenic parent strain. , 2001, Microbial pathogenesis.
[55] Jonathan W. Yewdell,et al. A novel influenza A virus mitochondrial protein that induces cell death , 2001, Nature Medicine.
[56] R. Webster,et al. A mouse model of dual infection with influenza virus and Streptococcus pneumoniae , 2001 .
[57] K. Nichol,et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. , 2001, The Journal of infectious diseases.
[58] M. Bergeron,et al. Microbiological and inflammatory factors associated with the development of pneumococcal pneumonia. , 2001, The Journal of infectious diseases.
[59] J. McCullers,et al. Molecular pathogenesis of pneumococcal pneumonia. , 2001, Frontiers in bioscience : a journal and virtual library.
[60] K. Melén,et al. Survey Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression , 1998 .
[61] J. Hedlund,et al. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study , 2001, The Lancet.
[62] Theresa M. Wizemann,et al. Use of a Whole Genome Approach To Identify Vaccine Molecules Affording Protection against Streptococcus pneumoniae Infection , 2001, Infection and Immunity.
[63] T. Mitchell,et al. Proinflammatory interactions of pneumolysin with human neutrophils. , 2001, The Journal of infectious diseases.
[64] P. Ward,et al. Oral oseltamivir treatment of influenza in children , 2001, The Pediatric infectious disease journal.
[65] T. Demaria,et al. Effect of Adenovirus Type 1 and Influenza a Virus on Streptococcus Pneumoniae Nasopharyngeal Colonization and Otitis Media in the Chinchilla , 2000, The Annals of otology, rhinology, and laryngology.
[66] E. Tuomanen,et al. Role of Novel Choline Binding Proteins in Virulence of Streptococcus pneumoniae , 2000, Infection and Immunity.
[67] J. Heitman. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases , 2000 .
[68] Laurent Kaiser,et al. Influenza virus neuraminidase inhibitors , 2000, The Lancet.
[69] E. Lewis,et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children , 2000, The Pediatric infectious disease journal.
[70] L. Simonsen,et al. The impact of influenza epidemics on hospitalizations. , 2000, The Journal of infectious diseases.
[71] John J. Treanor,et al. Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza , 2000 .
[72] R. Couch,et al. Impact of respiratory virus infections on persons with chronic underlying conditions. , 2000, JAMA.
[73] J. Paton,et al. Additive Attenuation of Virulence ofStreptococcus pneumoniae by Mutation of the Genes Encoding Pneumolysin and Other Putative Pneumococcal Virulence Proteins , 2000, Infection and Immunity.
[74] J. Carlin,et al. Bacterial etiology of serious infections in young infants in developing countries: results of a multicenter study. The WHO Young Infants Study Group. , 1999, The Pediatric infectious disease journal.
[75] M. Meltzer,et al. The economic impact of pandemic influenza in the United States: priorities for intervention. , 1999, Emerging infectious diseases.
[76] J. Scott,et al. The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known. , 1999, Vaccine.
[77] D. Golenbock,et al. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. , 1999, Journal of immunology.
[78] T. Demaria,et al. Effect of lacto-N-neotetraose, asialoganglioside-GM1 and neuraminidase on adherence of otitis media-associated serotypes of Streptococcus pneumoniae to chinchilla tracheal epithelium. , 1999, Microbial pathogenesis.
[79] Giebink Gs. Otitis media: the chinchilla model. , 1999 .
[80] Giebink Gs,et al. Otitis media: the chinchilla model. , 1999, Microbial drug resistance.
[81] Katsuhiko Omoe,et al. Phylogenetic Analysis of the Entire Genome of Influenza A (H3N2) Viruses from Japan: Evidence for Genetic Reassortment of the Six Internal Genes , 1998, Journal of Virology.
[82] K. Nichol,et al. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. , 1998, Archives of internal medicine.
[83] L. Simonsen,et al. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. , 1998, The Journal of infectious diseases.
[84] F. Hayden,et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. , 1998, The New England journal of medicine.
[85] F. Hayden,et al. Effect of rimantadine treatment on clinical manifestations and otologic complications in adults experimentally infected with influenza A (H1N1) virus. , 1998, The Journal of infectious diseases.
[86] M. Bergeron,et al. Cytokine Kinetics and Other Host Factors in Response to Pneumococcal Pulmonary Infection in Mice , 1998, Infection and Immunity.
[87] F. Hayden,et al. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. , 1998, The Journal of clinical investigation.
[88] L. Simonsen,et al. The impact of influenza epidemics on mortality: introducing a severity index. , 1997, American journal of public health.
[89] C. Rosenow,et al. Contribution of novel choline‐binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae , 1997, Molecular microbiology.
[90] G L Ada,et al. Options for the control of influenza III. Cairns, North Queensland, Australia (4-9 May 1996). , 1997, Vaccine.
[91] S. Schultz-Cherry,et al. Influenza virus neuraminidase activates latent transforming growth factor beta , 1996, Journal of virology.
[92] T. van der Poll,et al. Interleukin-10 impairs host defense in murine pneumococcal pneumonia. , 1996, The Journal of infectious diseases.
[93] S. de Bentzmann,et al. Receptors in the Pseudomonas aeruginosa adherence to injured and repairing airway epithelium. , 1996, American journal of respiratory and critical care medicine.
[94] C. Rosenow,et al. Pyruvate oxidase, as a determinant of virulence in Streptococcus pneumoniae , 1996, Molecular microbiology.
[95] E. Tuomanen,et al. PAf receptor anchors Streptococcus pneumoniae to activated human endothelial cells. , 1996, Advances in experimental medicine and biology.
[96] E. Tuomanen,et al. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor , 1995, Nature.
[97] E. Walter,et al. Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care. , 1995, Archives of pediatrics & adolescent medicine.
[98] K. Nichol,et al. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. , 1994, The New England journal of medicine.
[99] S. Wahl,et al. Transforming growth factor β: a matter of life and death , 1994 .
[100] S. Wahl,et al. Transforming growth factor beta: a matter of life and death. , 1994, Journal of leukocyte biology.
[101] D. Kaiser,et al. Clinical effectiveness of influenza vaccination in Manitoba. , 1993, JAMA.
[102] D. Lim,et al. Effect of Influenza a Virus on Ciliary Activity and Dye Transport Function in the Chinchilla Eustachian Tube , 1993, The Annals of otology, rhinology, and laryngology.
[103] M. Plotkowski,et al. Cellular and molecular mechanisms of bacterial adhesion to respiratory mucosa. , 1993, The European respiratory journal.
[104] D. Lim,et al. Changes in the structure of the cell surface carbohydrates of the chinchilla tubotympanum following Streptococcus pneumoniae-induced otitis media. , 1992, Microbial pathogenesis.
[105] P. Andrew,et al. Streptococcus pneumoniae produces at least two distinct enzymes with neuraminidase activity: cloning and expression of a second neuraminidase gene in Escherichia coli , 1991, Infection and immunity.
[106] T. Heikkinen,et al. Influenza vaccination in the prevention of acute otitis media in children. , 1991, American journal of diseases of children.
[107] P. Andrew,et al. The effect of Streptococcus pneumoniae pneumolysin on human respiratory epithelium in vitro. , 1990, Microbial pathogenesis.
[108] S. Weiss. Tissue destruction by neutrophils. , 1989, The New England journal of medicine.
[109] H. Klenk,et al. Synergistic role of staphylococcal proteases in the induction of influenza virus pathogenicity. , 1987, Virology.
[110] H. Klenk,et al. Role of Staphylococcus protease in the development of influenza pneumonia , 1987, Nature.
[111] J. Babish,et al. 4-Ipomeanol-induced effects on Sendai viral pneumonia in mice. , 1987, The American journal of pathology.
[112] M. Plotkowski,et al. Adherence of type I Streptococcus pneumoniae to tracheal epithelium of mice infected with influenza A/PR8 virus. , 1986, The American review of respiratory disease.
[113] R. Glew,et al. Experimental Alteration of Chinchilla Middle Ear Mucosae by Bacterial Neuraminidase , 1986, The Annals of otology, rhinology, and laryngology.
[114] B. Gray,et al. Clinical and epidemiologic studies of pneumococcal infection in children , 1986, Pediatric infectious disease.
[115] C. Garrard,et al. Modifications of lung clearance mechanisms by acute influenza A infection. , 1985, The Journal of laboratory and clinical medicine.
[116] M. Boyd,et al. Pulmonary endothelial and bronchiolar epithelial lesions induced by 4-ipomeanol in mice. , 1985, The American journal of pathology.
[117] P. Quie,et al. Influenza A virus-induced polymorphonuclear leukocyte dysfunction in the pathogenesis of experimental pneumococcal otitis media , 1982, Infection and immunity.
[118] P. Quie,et al. Depression of monocyte and polymorphonuclear leukocyte oxidative metabolism and bactericidal capacity by influenza A virus , 1982, Infection and immunity.
[119] Glezen Wp,et al. SERIOUS MORBIDITY AND MORTALITY ASSOCIATED WITH INFLUENZA EPIDEMICS , 1982 .
[120] W. P. Glezen,et al. Serious morbidity and mortality associated with influenza epidemics. , 1982, Epidemiologic reviews.
[121] R. Couch,et al. Effects of infection with influenza virus on the function of polymorphonuclear leukocytes. , 1981, The Journal of infectious diseases.
[122] P. Quie,et al. Polymorphonuclear leukocyte dysfunction during influenza virus infection in chinchillas. , 1981, The Journal of infectious diseases.
[123] P. Wright,et al. Differing virulence of H1N1 and H3N2 influenza strains. , 1980, American journal of epidemiology.
[124] B. Gray,et al. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. , 1980, The Journal of infectious diseases.
[125] R. Kanner,et al. Effect of Viral Infections on Pulmonary Function in Patients with Chronic Obstructive Pulmonary Diseases , 1980, The Journal of infectious diseases.
[126] John E. Bennett,et al. Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .
[127] R. Kanner,et al. Interactions between Viruses and Bacteria in Patients with Chronic Bronchitis , 1976, The Journal of infectious diseases.
[128] W. T. Low,et al. Effect of virus infections on polymorph function in children. , 1976, British medical journal.
[129] A. Langmuir. William Farr: founder of modern concepts of surveillance. , 1976, International journal of epidemiology.
[130] M. Sande,et al. Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types. , 1975, The Journal of infectious diseases.
[131] C. G. Loosli,et al. The destruction of type 2 pneumocytes by airborne influenza PR8-A virus; its effect on surfactant and lecithin content of the pneumonic lesions of mice. , 1975, Chest.
[132] G. Horner,et al. Effect of uncomplicated, presumptive influenza on the diffusing capacity of the lung. , 1973, The American review of respiratory disease.
[133] W. J. Housworth,et al. The age distribution of excess mortality during A2 Hong Kong influenza epidemics compared with earlier A2 outbreaks. , 1971, American journal of epidemiology.
[134] J. Sanford,et al. Pulmonary function in uncomplicated influenza. , 1969, The American review of respiratory disease.
[135] Loosli Cg. Synergism between respiratory viruses and bacteria. , 1968 .
[136] C. G. Loosli. Synergism between respiratory viruses and bacteria. , 1968, The Yale journal of biology and medicine.
[137] E. D. Kilbourne,et al. THE INFLUENCE OF INFLUENZA VIRUS INFECTION ON EXOGENOUS STAPHYLOCOCCAL AND ENDOGENOUS MURINE BACTERIAL INFECTION OF THE BRONCHOPULMONARY TISSUES OF MICE , 1961, The Journal of experimental medicine.
[138] C. Stuart-harris,et al. Influenza and its complications. , 1959, British medical bulletin.
[139] L. Gottlieb,et al. Asian influenza A in Boston, 1957-1958. I. Observations in thirty-two influenza-associated fatal cases. , 1959, A.M.A. archives of internal medicine.
[140] L. Gottlieb,et al. Asian influenza A in Boston, 1957-1958. II. Severe staphylococcal pneumonia complicating influenza. , 1959, A.M.A. archives of internal medicine.
[141] D. E. Rogers,et al. Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza. , 1959, The Journal of clinical investigation.
[142] Cm Martin. Asian influenza A in Boston, 1957-1958 , 1959 .
[143] J. Scadding. PULMONARY complications of influenza. , 1952, Lancet.
[144] D. Tyrrell. The pulmonary complications of influenza as seen in Sheffield in 1949. , 1952, The Quarterly journal of medicine.
[145] S. D. Collins,et al. Trends and epidemics of influenza and pneumonia: 1918-1951. , 1951, Public health reports.
[146] C. Stuart-harris,et al. VIRUS AND RICKETTSIAL DISEASES , 1951 .
[147] C. G. Harford,et al. PULMONARY EDEMA IN INFLUENZAL PNEUMONIA OF THE MOUSE AND THE RELATION OF FLUID IN THE LUNG TO THE INCEPTION OF PNEUMOCOCCAL PNEUMONIA , 1950, The Journal of experimental medicine.
[148] D. Tyrrell,et al. The relationship between influenza and pneumonia , 1949, Epidemiology and Infection.
[149] T. Ward,et al. THE RELATION OF INFLUENZA VIRUS AND BACTERIA IN THE ETIOLOGY OF PNEUMONIA. , 1949, The Journal of clinical investigation.
[150] C. G. Harford,et al. EFFECT OF THE LESION DUE TO INFLUENZA VIRUS ON THE RESISTANCE OF MICE TO INHALED PNEUMOCOCCI , 1949, The Journal of experimental medicine.
[151] Gordon C. Brown. VIRUS and rickettsial diseases. , 1956, Research program. United States. Army. Medical Department.
[152] O. Woolpert,et al. REACTIONS OF MONKEYS TO EXPERIMENTAL MIXED INFLUENZA AND STREPTOCOCCUS INFECTIONS , 1947, The Journal of experimental medicine.
[153] C. Macleod,et al. Epidemic pneumococcal pneumonia; description of the epidemic. , 1946, American journal of hygiene.
[154] C. Macleod,et al. Epidemic pneumococcal pneumonia; pneumococcal carrier studies. , 1946, American journal of hygiene.
[155] H. Wilson,et al. Reactions of monkeys to experimentally induced influenza virus A infection; an analysis of the relative rôles of humoral and cellular immunity under conditions of optimal or deficient nutrition. , 1946, The Journal of experimental medicine.
[156] O. Woolpert,et al. REACTIONS OF MONKEYS TO EXPERIMENTALLY INDUCED INFLUENZA VIRUS A INFECTION , 1946, The Journal of experimental medicine.
[157] M. Finland,et al. INFLUENZA VIRUS ISOLATIONS AND SEROLOGICAL STUDIES MADE IN BOSTON DURING THE WINTER OF 1943-1944. , 1945, The Journal of clinical investigation.
[158] T. Francis,et al. Combined Infection of Mice with H. Influenzae and Influenza Virus by the Intranasal Route , 1945 .
[159] S. D. Collins. Influenza and Pneumonia Excess Mortality at Specific Ages in the Epidemic of 1943-44, with Comparative Data for Preceding Epidemics. , 1945 .
[160] J. Enders,et al. A Study of Influenza in Boston during the Winter of 1940–1941 , 1941 .
[161] J. Scadding. LUNG CHANGES IN INFLUENZA , 1937 .
[162] C. Andrewes,et al. Influenza: Observations on the Recovery of Virus from Man and on the Antibody Content of Human Sera , 1935 .
[163] S. D. Collins. Excess Mortality from Causes other than Influenza and Pneumonia during Influenza Epidemics. , 1932 .
[164] P. Lewis,et al. SWINE INFLUENZA , 1931, The Journal of experimental medicine.
[165] S. D. Collins. Influenza-Pneumonia Mortality in a Group of about 95 Cities in the United States, 1920-1929. , 1930 .
[166] P. Laidlaw,et al. Studies in dog-distemper: III.—The nature of the virus. , 1926 .
[167] P. Laidlaw,et al. Studies in dog-distemper , 1926 .
[168] P. Laidlaw,et al. Studies in dog-distemper: II.—Experimental distemper in the dog , 1926 .
[169] F. R. Packard. Translation of Selected Passages from De L’Auscultation Médiate , 1923, Annals of Medical History.
[170] C. T. Butterfield,et al. Inhalation Experiments on Influenza and Pneumonia, and on the Importance of Spray-Borne Bacteria in Respiratory Infections , 1920 .
[171] A. Abrahams,et al. A further Investigation INTO INFLUENZO-PNEUMOCOCCAL AND INFLUENZO-STREPTOCOCCAL SEPTICÆMIA: EPIDEMIC INFLUENZAL "PNEUMONIA" OF HIGHLY FATAL TYPE AND ITS RELATION TO "PURULENT BRONCHITIS." , 1919 .
[172] W. J. Wilson,et al. BACTERIOLOGICAL AND PATHOLOGICAL OBSERVATIONS ON INFLUENZA AS SEEN IN FRANCE DURING 1918 , 1919 .
[173] G. Swift,et al. INFLUENZA AND INFLUENZAL PNEUMONIA AT FORT RILEY, KANSAS: FROM SEPT. 15 TO NOV. 1, 1918 , 1919 .
[174] R. Muir,et al. Observations ON INFLUENZA AND ITS COMPLICATIONS , 1919, British medical journal.
[175] R. Russell. Epidemic Influenza , 1893, Nature.
[176] Â.,et al. INFLUENZA VIRUS ISOLATIONS AND SEROLOGICAL STUDIES MADE IN BOSTON DURING THE WINTEROF 1943-1944 By MAXWELL FINLAND , MILDRED , 2022 .